From pharma to fractional CMO

Before LeRiche Marketing existed, Eric spent 15 years in pharmaceutical sales and marketing, one of the most regulated, highest scrutiny industries in business. If a claim couldn't survive scrutiny, it didn't ship. That standard is what he brought with him when he founded LeRiche Marketing 19 years ago, working mostly as a fractional CMO ever since.

It's also part of why some growth engagements work on a performance basis. For businesses with a high-ticket offer, strong margins, a good closing average, and a sales cycle usually under six months, Eric invests his own time and team resources upfront in exchange for commission on the new business generated. It's not available to every business, not because we can't help otherwise, but because those specific conditions are what make a commission structure viable for both sides. Whether it applies starts with a conversation.

Eric calls himself the locomotive. He's the one pulling, and he's not slowing down, including staying hands on with how fast AI itself is moving. But no one person can track everything alone, so a few people on the team, AI nerds by any reasonable definition, dig into the details full time and bring it back to him. Eric still calls the shots on what's worth building. They just make sure he's never working from stale information.